Oncology Analytics Revenue and Competitors

Claim your profile

Miami, FL USA

Location

#2782

Growjo Ranking

Estimated Revenue & Valuation

  • Oncology Analytics's estimated annual revenue is currently $17.1M per year.(i)
  • Oncology Analytics received $21.0M in venture funding in November 2018.
  • Oncology Analytics's estimated revenue per employee is $81,818
  • Oncology Analytics's total funding is $56.5M.

Employee Data

  • Oncology Analytics has 209 Employees.(i)
  • Oncology Analytics grew their employee count by 32% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$57M192N/AN/AN/A

Oncology Analytics, Inc. provides health plans with an evidence-based, technologically driven approach to utilization management, which is purpose-built for oncology. Used by physicians to support over 2.5 million health plan members in the US and Puerto Rico, our e-Prior Authorization platform is updated daily to accurately reflect more than 6,000 oncology treatment protocols for anti-cancer treatment across all cancer types and stages, including chemotherapy, radiation therapy, precision medicine, targeted therapy and supportive care.

keywords:Enterprise Software,Finance,Health It,Healthcare,Information Security,Medical Diagnostics,Pharmaceuticals,Security

$56.5M

Total Funding

209

Number of Employees

$17.1M

Revenue (est)

32%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Oncology Analytics News

2022-04-20 - Global Veterinary Oncology Market to See Major Growth by ...

The Brainy Insights recently published a report on the Global Veterinary Oncology market, which is a 150+ pages deep analysis of the Veterinary Oncology...

2022-04-06 - Tongji hospital selects RayStation

RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data.

2022-03-30 - CFO Torbjörn Wingårdh leaves RaySearch

RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data.

2021-03-31 - Pyxis Oncology closes $152M Series B

Pyxis Oncology, a developer of therapeutics for difficult-to-treat cancers, has raised a $152 million Series B co-led by Arix Bioscience and RTW Investments. Perceptive Advisors, RA Capital Management, Pfizer Ventures and a host of others participated in the round. The investment brings the Camb ...

2020-09-10 - Oncology Analytics Launches Pharmacy Consulting Services

ATLANTA, Sept. 10, 2020 /PRNewswire/ -- Oncology Analytics, a leading data analytics and technology-enabled services company dedicated to helping health plans, providers, and patients with solutions that are purpose-built for oncology, has announced the launch of Pharmacy Consulting Services, ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$65M21917%N/A
#2
$117.1M3470%N/A
#3
$104.3M365N/AN/A
#4
$112.8M410N/AN/A
#5
$132.4M4229%N/A

Oncology Analytics Funding

DateAmountRoundLead InvestorsReference
2016-03-09$7.5MUndisclosedBlueCross BlueShield Venture PartnersArticle
2018-11-07$21.0MBOak HC/FTArticle

Oncology Analytics Executives


NameTitle
Ashley BrevdaCorporate Counsel & Chief Compliance Officer
David FusariCTO
Jim CullinanCFO
Mike CollettChief Growth Officer
Rick DeanChief Executive Officer | Board Member
Andrew NordenChief Medical Officer
Linda GeilerExecutive Assistant to the CEO
Laura BoboltsSVP, Pharmacy
Steve DavisSenior Vice President Business Development
Vidya ShankarVice President of Data Development
Sara ZywickiSVP of Product Management